Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies
Clinical trial NCT00521859 · COMPLETED
Trial details
- NCT number
- NCT00521859
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2010-12-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.